3Emanuele DA, Stefano DC, Danilo T, et al. Detemainants of plasma levels of brain natfiuretic peptide sfter acute ischemic strok or TIA[J]. J neuro Sci,2007,260:139 - 142.
4Takahashi K, Totsme K, Sone M, et al. Human Brain natriuretie peptide- like irnmunoreactivity in human brain[ J]. Peptides, 1992,13 : 121 - 123.
5Estrada V, Tellez MJ, Moya J, et al. High pla,maa levels of endpthelin-I and atrial natriuretic peptide in patient with acute ischemic stroke[J]. Am JHypertens, 1994,7:1085 - 1089.
8Silyet H, Young XY, Walleigh D, et al. Brain natriuretic peptide is ele- vated in outpatients with atrial fibrillation[J]. Am J Cardiol,2003,92:124 - 127.
6Pedram A, Razandi M, Hu RM, et al. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Bio Chem, 1997, 272: 17097- 17103.
7Rubattu S, Stanzione R, Angelantionio e, et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke, 2004, 35: 814-818.
9Melanson SE, Lewandrowski EL. Laboratory testing for B-type natriuretic peptides (BNP and NT-proBNP): clinical usefulness, utilization, and impact on hospital operations. Am J Clin Pathol, 2005, 124(Suppl): S122-S128.
10Maldkallio AM, Makikallio TH, Korpelainen Jr, et al. Natriuretic peptides and Mortality after stroke. Stroke, 2005, 36: 1016-1020.
1Kim, H.,Miller, L.M.,Fedulow, I. et al.Kinematic data analysis for post-stroke patients following bilateral versus unilateral rehabilitation with an upper limb wearable robotic system[J]. IEEE ,2013,21 (2): 153-164.
